AT-004

N/A

Report date: 2023/09/18 15:49:19

Base Information

Drug NameAT-004
Drug Alias NameAT-004
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Adenosine A2a receptor
TargetsAdenosine A2a receptor
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesAnpu Biomedical Technology (Shenzhen) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnpu Biomedical Technology (Shenzhen) Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A